Writing Group Disclosures

Writing Group MemberEmploymentResearch GrantOther Research SupportSpeakers’ Bureau/HonorariaExpert WitnessOwnership InterestConsultant/Advisory BoardOther
Bruce OvbiageleMUSCNoneNoneNoneNoneNoneNoneNone
Larry B. GoldsteinDuke University and Durham VANoneNoneNoneNoneNoneNoneNone
Randall T. HigashidaUCSF Medical CenterNoneNoneNoneNoneNoneNoneNone
Virginia J. HowardUniversity of Alabama at BirminghamNIHNoneNoneNoneNoneNoneNone
S. Claiborne JohnstonUniversity of California, San FranciscoNoneNoneNoneNoneNoneNoneNone
Olga A. KhavjouRTINoneNoneNoneNoneNoneCDCNone
Daniel T. LacklandMedical University of South CarolinaNoneNoneNoneNoneNoneNoneNone
Judith H. LichtmanYale UniversityNoneNoneNoneNoneNoneNoneNone
Stephanie MohlAmerican Heart AssociationNoneNoneNoneNoneNoneNoneNone
Ralph L. SaccoUniversity of MiamiNoneNoneNoneNoneNoneNoneNone
Jeffrey L. SaverGeffen School of Medicine at UCLANIH-FAST-MAG Phase 3 trial, PI;
NIH–Acute Stroke Research Center, PI
NoneNoneNoneNoneCoAxia*; EV3*; Telecris*; Sygnis*; BrainsGate*; Ferrer*None
Justin G. TrogdonRTI InternationalNoneNoneNoneNoneNoneCDCNone
  • This table represents the relationships of writing group members that may be perceived as actual or reasonably perceived conflicts of interest as reported on the Disclosure Questionnaire, which all members of the writing group are required to complete and submit. A relationship is considered to be “significant” if (1) the person receives $10 000 or more during any 12-month period, or 5% or more of the person’s gross income; or (2) the person owns 5% or more of the voting stock or share of the entity, or owns $10 000 or more of the fair market value of the entity. A relationship is considered to be “modest” if it is less than “significant” under the preceding definition.

  • * Modest.

  • Significant.